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Pathogenic variants in surfactant proteins SP-B and SP-C cause surfactant deﬁciency and interstitial lung disease. Surfactant proteins
are synthesized as precursors (proSP-B, proSP-C), trafﬁcked, and
processed via a vesicular-regulated secretion pathway; however,
control of vesicular trafﬁcking events is not fully understood.
Through the Undiagnosed Diseases Network, we evaluated a child
with interstitial lung disease suggestive of surfactant deﬁciency.
Variants in known surfactant dysfunction disorder genes were not
found in trio exome sequencing. Instead, a de novo heterozygous
variant in RAB5B was identiﬁed in the Ras/Rab GTPases family
nucleotide binding domain, p.Asp136His. Functional studies were
performed in Caenorhabditis elegans by knocking the proband
variant into the conserved position (Asp135) of the ortholog,
rab-5. Genetic analysis demonstrated that rab-5[Asp135His] is
damaging, producing a strong dominant negative gene product.
rab-5[Asp135His] heterozygotes were also defective in endocytosis and early endosome (EE) fusion. Immunostaining studies of the
proband’s lung biopsy revealed that RAB5B and EE marker EEA1
were signiﬁcantly reduced in alveolar type II cells and that mature
SP-B and SP-C were signiﬁcantly reduced, while proSP-B and
proSP-C were normal. Furthermore, staining normal lung showed
colocalization of RAB5B and EEA1 with proSP-B and proSP-C. These
ﬁndings indicate that dominant negative–acting RAB5B Asp136His
and EE dysfunction cause a defect in processing/trafﬁcking to produce mature SP-B and SP-C, resulting in interstitial lung disease,
and that RAB5B and EEs normally function in the surfactant secretion pathway. Together, the data suggest a noncanonical function
for RAB5B and identify RAB5B p.Asp136His as a genetic mechanism for a surfactant dysfunction disorder.
RAB5B j Caenorhabditis elegans j endocytosis j surfactant proteins j
surfactant dysfunction disorder
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ab5, a member of the Ras/Rab superfamily of small
GTPases (1, 2), is a master regulator of the endocytic pathway, controlling early endosome (EE) trafficking in animals (3,
4). Guanosine-5’-triphosphate (GTP)-bound Rab5 is active and
associated with the EE membrane via its C-terminal isoprenoid
modification. In the endocytic pathway, active Rab5 promotes
the heterotypic fusion of nascent endocytic vesicles with EEs
and the homotypic fusion of cargo-containing EE vesicles with
each other. In contrast, guanosine 50 -diphosphate (GDP)bound Rab5 is inactive and resides in the cytoplasm. Effector
proteins promote EE vesicle fusion and cycling between the
GTP- and GDP-bound states of Rab5 (5–7). In addition to its
canonical endocytic function, Rab5 has noncanonical functions:
for example, in promoting fusion of nascent sorting vesicles
PNAS 2022 Vol. 119 No. 6 e2105228119

with EEs in the regulated secretion pathway in mast cells and
in the Drosophila salivary gland (8, 9).
Lung surfactant is a protein–lipid mixture that lines the
air–liquid surface of the lung alveolar epithelium, reducing surface tension to prevent alveolar collapse and enhance lung
compliance during breathing (10, 11). There are four major
lung surfactant proteins; hydrophobic SP-B and SP-C function
in the formation of the protein–lipid matrix that lines the alveolar epithelium, while hydrophilic SP-A and SP-D are collectin
family members that function in innate immunity. The regulated surfactant protein secretion pathway in alveolar type II
(AT2) cells commences with translation in the endoplasmic
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reticulum (ER) of precursor proteins proSP-B and proSP-C,
which contain an N-terminal propeptide and a C-terminal mature
peptide (12–15). proSP-B and proSP-C are trafficked through the
Golgi, where they bud into nascent sorting vesicles that progress
to the multivesicular body (MVB) and then, transit to the lamellar body. Acidification in the MVB and lamellar body stimulates
proteolytic processing to mature SP-B and SP-C and their association with phospholipids. Surfactant protein–lipid complexes are
stored in the lamellar body for stimulus-induced secretion. Factors that control the early steps and trafficking of proSP-B– and
proSP-C–containing vesicles to the MVB are not well understood
(16–18).
Pathogenic variants in the genes that encode SP-B and SP-C
(SFTPB and SFTPC) and genes that are involved in surfactant
production (ABCA3 and NKX2-1) result in surfactant dysfunction disorders, one of the genetic causes of interstitial lung disease (ILD) (10, 19–21). Biallelic loss-of-function variants in
SFTPB result in full-term infants with severe respiratory distress
syndrome, which is typically lethal within the first few months
after birth (22). In contrast, dominant variants in SFTPC result
in lung diseases with variable penetrance and expressivity, ranging from neonatal respiratory distress syndrome to ILD in the
fifth and sixth decades of life (23). Genetic screening of full-term
infants with lethal surfactant dysfunction disorders identified
cases that lacked variants in the known causal genes, indicating
that there are yet to be identified genes that function in surfactant production (24–26), which is not surprising given the complex biology of the regulated surfactant secretion pathway.
Here, we describe a female child identified through the
Undiagnosed Diseases Network (UDN) (27) presenting with
ILD suggestive of a surfactant dysfunction disorder, dysmorphic features, and global developmental delay. Trio exome
sequencing identified that the proband carried a de novo heterozygous c.406G > C [NM_002868.3], p.Asp136His missense
variant in RAB5B, a gene not previously associated with disease. We exploited the facile genetics and the well-developed
assays for endocytosis and EEs in Caenorhabditis elegans
(28–30) to assess the functional consequences of the proband’s
RAB5B variant when modeled in the worm ortholog (SI
Appendix, Fig. S1). The goals of the functional analysis were to
determine if the variant was damaging in vivo, to provide
insight into the genetic mechanism of the de novo dominant
presentation, and to assess alterations in EE biology. We examined the proband’s lung tissue to understand the basis of the
ILD as well as normal donor lung tissue to assess the relationship of RAB5B to the regulated surfactant secretion pathway
(SI Appendix, Fig. S1). Our findings indicate that the RAB5B
variant disrupts maturation of surfactant proteins B and C,
resulting in ILD in the proband, and that RAB5B and EEs
function in the regulated lung surfactant secretion pathway.

ground glass opacities, areas of consolidation, and peripheral
cysts, consistent with ILD and suggestive of a surfactant dysfunction disorder (Fig. 1C).
The proband developed chronic tachypnea and had frequent
hospitalizations for respiratory distress. At 17 mo of age, she
required continuous supplemental oxygen, and a lung biopsy was
performed. Histologic examination of lung tissue showed alveolar proteinosis, AT2 cell hyperplasia, lobar remodeling, and early
fibrosis, consistent with a chronic disorder of surfactant dysfunction (Fig. 1D). Transmission electron microscopy was not performed. Clinical immunostaining of the lung tissue reported
normal levels of ABCA3, TTF-1, SP-D, and proSP-C within AT2
cells but diminished SP-B levels. Despite therapies for ILD, the
child died at the age of 2 y from respiratory failure.
A chromosomal microarray analysis (Baylor Genetics; CMAHR+SNP version 11.2) was performed and was nondiagnostic.
Trio exome sequencing was performed. No variants, losses, or
gains were found in genes known to be involved in surfactant
metabolism (SI Appendix, Table S1). Instead, a de novo variant in
RAB5B was identified, corresponding to p.Asp136His (p.D136H,
c.406G > C, NM_002868.3), and was subsequently confirmed by
Sanger sequencing (Fig. 1E). The variant is not found in the
sequence database Genome Aggregation Database (gnomAD) of
∼140,000 individuals (https://gnomad.broadinstitute.org; accessed
October 2021) (31). The missense change is predicted to be damaging based on a combined annotation dependent depletion
(CADD) score of 29.6 and a MutationTaster score of 81 (32, 33).
RAB5B is likely not a haplo-insufficient gene based on tolerance
to heterozygous loss-of-function variants, with an observed to
expected ratio of 0.19 to 0.75, and probability of being loss-offunction intolerant (pLI) = 0.03 (gnomAD v2.1.1).
In humans, RAB5 has EE vesicular fusion functions mediated by three paralogous genes RAB5A, RAB5B, and RAB5C,
compared with single ancestral orthologs in C. elegans (rab-5)
and Drosophila melanogaster (Rab5) (34) (Fig. 1F), suggesting
redundant and unique functions for the paralogs in humans.
The RAB5B residue p.D136 is highly conserved and resides in
the fourth region of the small GTPase nucleotide binding
domain (Fig. 1G and SI Appendix, Fig. S2A), indicating that the
variant may disrupt nucleotide binding, hydrolysis, and/or
release. RAS family GTPases have a nearly identical nucleotide
binding domain as RAB family GTPases (35). In a forward
genetic screen, dominant negative mutations in the C. elegans
ortholog of HRAS, let-60, were identified (36). One of these,
D119N (allele sy93), is in the fourth region of the nucleotide
binding domain of let-60 at the residue corresponding to human
RAB5B p.D136 and C. elegans rab-5 D135 (Fig. 1G and SI
Appendix, Fig. S2 B and C). These findings led us to propose
that the phenotype of the proband results from the de novo
heterozygous RAB5B p.D136H variant encoding a dominant
negative gene product.

Results

C. elegans rab-5[D135H] Is Damaging, Producing a Dominant
Negative Gene Product. To investigate the functional significance
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ILD and Developmental Delay in a Proband with a De Novo Variant
in RAB5B. We identified a female of Pakistani ancestry with

global developmental delay, dysmorphic features, and ILD
leading to progressive respiratory failure and death at age 2.
The proband was born to a 39-y-old mother and a 46-y-old
father at 34-wk gestation by Caesarean section and weighed 2.7
kg (91st percentile). She had no respiratory symptoms at birth.
Evaluation at 6 mo was significant for hypotonia, a broad nasal
bridge with telecanthus, short squared digits, and overlapping
second toes. She had profound developmental delay with static
encephalopathy. Brain magnetic resonance imaging and electroencephalogram were normal. At 11 mo of age, she had digital clubbing (Fig. 1A) and a chest radiograph that showed
hyperinflation and diffuse interstitial opacities (Fig. 1B). A
computed tomography scan of the chest demonstrated diffuse
2 of 10 j PNAS
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of RAB5B p.D136H and the genetic basis of the dominant presentation, we modeled the proband’s variant in C. elegans. We
generated rab-5[D135H] and the rab-5[D135D] control animals
employing CRISPR-Cas9 editing at the endogenous rab-5 locus
on chromosome I (SI Appendix, Fig. S3 and Table S2). rab-5
deletion [rab-5(del)] animals were homozygous lethal. Similarly,
the rab-5[D135H] homozygous animals were lethal, arrested at
the first larval stage (L1). In the variant heterozygotes, we quantitatively assessed organismal phenotypes, including locomotion
and size (Fig. 2B). The rab-5(del) and control rab-5[D135D] heterozygous animals were normal compared with wild-type animals. However, the rab-5[D135H] heterozygotes had a >40%
reduction in locomotion and a >20% reduction in size at 24 h
post-L4 larval stage. D135H is thus damaging to rab-5 function
Huang et al.
A dominant negative variant of RAB5B disrupts maturation of
surfactant protein B and surfactant protein C

A

B

D

C

E

F

Downloaded at SCHL MED LIB&77680003 on February 10, 2022

Fig. 1. Clinical features of the proband with a de novo variant in RAB5B. (A) Shortened broad ﬁngers with nail clubbing. (B) Hyperinﬂation of lungs and
interstitial opacities by chest radiograph (posterior–anterior and lateral views) at 7 mo of age. (C) Computed tomography of the lung at 11 mo of age
shows acute and chronic interstitial changes. (D) Lung biopsy stained with hematoxylin and eosin (higher-power details are in insets d1 and d2) shows
alveolar ﬁlling (d1; asterisk), AT2 cell hyperplasia (d1; bracket), remodeling (d2), and ﬁbrosis (d2). (Scale bars: D, 2.5 mm; d1 and d2, 100 μm.) (E) Dideoxy
(Sanger) sequencing traces from parents and the proband showing a de novo heterozygous variant in RAB5B, c.406G > C, p.Asp136His. (F) Phylogenetic
tree of Rab5 indicating the evolutionary orthologs and human paralogs. Alignment distance values are shown (Clustal Omega). C.e., C. elegans; D.m.,
D. melanogaster; H.s., Homo sapiens. (G) Alignment of the RAB5B sequence from H.s. residues 121 to 151 with orthologs from indicated species. The location of the variant edited in C. elegans corresponding to the conserved aspartate [D] in the proband is indicated (red arrow). The fourth region of the
conserved nucleotide binding domain (NKXD) is indicated (green bars above and below). Identical residues are shaded black; conserved residues are gray
(SI Appendix, Fig. S2).

and displays a dominant behavior not observed by rab-5(del),
consistent with a dominant negative gene product.
By definition, the phenotype of an antimorphic or dominant
negative mutation is suppressed by additional copies of the
wild-type gene product (37). To test for a dominant negative
genetic mechanism of rab-5[D135H], we introduced a genomic
wild-type rab-5 single-copy transgene into a chromosome II
safe harbor site (Fig. 2A) and assessed the effect of gene dosage on phenotype. We first confirmed that the wild-type singlecopy transgene behaves like the endogenous locus based on the
evidence that 1) two copies of rab-5 transgene fully rescued
rab-5(del) homozygotes in locomotion (SI Appendix, Fig. S3A),
2) transcript read counts from the endogenous locus and the
transgene were comparable (SI Appendix, Fig. S3B), and 3)
RAB-5 protein level was increased approximately twofold in
semiquantitative western blots (SI Appendix, Fig. S3 G and H).
We found that animals with wild-type rab-5 at the endogenous
locus and homozygous (two copies) for the chromosome II rab5 transgene (i.e., having four copies of wild-type rab-5) were
slightly longer but normal with respect to locomotion (Fig. 2C).
For the rab-5[D135H] heterozygous animals, one copy of the
rab-5 transgene partially rescued length and locomotion
defects, while two copies of the rab-5 transgene fully rescued
the rab-5[D135H] heterozygotes in both length and locomotion
(Fig. 2C). Combined, these results demonstrate that C. elegans
rab-5[D135H] has a strong dominant negative effect, requiring
three copies of the wild-type gene to suppress the variant’s poisonous effect. By extension, we propose that the human RAB5B
p.D136H is damaging, producing a dominant negative poisonous gene product and resulting in the proband’s phenotype.
rab-5[D135H] Heterozygous Animals Were Defective in Endocytosis
and EE Fusion. During endocytosis in animal cells, RAB5 medi-

ates the heterotypic fusion of nascent endocytic vesicles with
Huang et al.
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EEs and the homotypic fusion of EEs to become large ringshaped EEs when visualized in cross-section by confocal
microscopy. We first assessed the effect of rab-5[D135H] on
endocytic uptake, measuring fluid-phase endocytosis via clearance of secreted soluble green fluorescent protein (ssGFP) in
the body cavity by coelomocytes and receptor-mediated uptake
of yolk protein by oocytes (28, 38, 39). C. elegans coelomocytes
are scavenger cells that nonspecifically endocytose fluid from
the body cavity (pseudocoelom) (Fig. 3A). Under normal conditions, ssGFP in the body cavity, secreted from muscle cells, is
efficiently endocytosed and cleared by the coelomocytes. As
expected, in wild-type animals and control rab-5[D135D] heterozygotes, the majority of ssGFP was in the coelomocytes (Fig.
3A and SI Appendix, Fig. S4A). In contrast, rab-5[D135H] heterozygous animals failed to clear ssGFP from the body cavity,
indicating a blockage of endocytic trafficking (Fig. 3B and SI
Appendix, Fig. S4A). Similarly, rab-5[D135H] heterozygotes
failed to accumulate yolk protein, synthesized by the intestine,
into oocytes, indicating a blockage of receptor-mediated yolk
protein endocytosis (SI Appendix, Fig. S4 B–E). In both assays,
rab-5(del) heterozygotes were not significantly different from
wild-type animals, corroborating the organismal length and
locomotion data and indicating that rab-5 is not haploinsufficient in C. elegans.
We next assessed the effect of rab-5[D135H] on EE fusion by
visualizing the size of EEs in coelomocytes using the marker
2xFYVE::GFP, which binds to phosphatidylinositol-3-phosphate
(PI(3)P)-modified lipids on EEs (40, 41). rab-5(del) and control
rab-5[D135D] heterozygous animals contained various stages of
EEs, ranging from small-sized puncta to large ring-shaped structures (Fig. 3 C, D, and F), suggesting continuous endosomal
trafficking in these animals. In contrast, EEs in rab-5[D135H]
heterozygotes were all puncta sized and failed to mature into
larger ring-shaped EEs (Fig. 3 E and F), presumably due to the
PNAS j 3 of 10
https://doi.org/10.1073/pnas.2105228119
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synthesis, from the LungMAP human single-cell RNA sequencing
(RNA-seq) dataset (42). The AT2 cell Uniform Manifold Approximation and Projection (UMAP) clusters from day-1 and 21-mo
datasets were identified using marker genes SFTPB and SFTPC
(SI Appendix, Figs. S5 and S6). For both day 1 and 21 mo, RAB5B,
RAB5A, and RAB5C were all expressed in AT2 cells as well as
other lung cell types (SI Appendix, Fig. S7), with RAB5A expression
lower than RAB5B and RAB5C. Detection of RAB5B mRNA in
these postnatal cells is consistent with the RAB5B p.D136H allele
affecting AT2 cell function. We propose that RAB5B dysfunction
leads to a defect in surfactant protein trafficking/processing, resulting in the child’s ILD (Figs. 1D and 4A).
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dominant negative RAB-5 D135H disrupting EE fusion. We conclude that rab-5[D135H] is defective in EE fusion events, leading
to multi-cell type defects in endocytic uptake and EE function.
By extension, we suggest that RAB5B p.D136H produces a dominant negative RAB5B GTPase that disrupts EE fusion events.
However, as humans have three RAB5 paralogs, there is likely
additional biological complexity that arises from potential genetic
redundancy and possible paralog-specific RAB5B function.
Disruption of RAB5B Accumulation in the Proband Lung. We next
sought to connect the de novo dominant negative RAB5B
p.D136H allele identified in the proband with ILD and features of
a surfactant dysfunction disorder (Fig. 1). From the proband lung
biopsy, fixed tissue was available for antibody staining; unfortunately, lung tissue was not available for transmission electron
microscopy or western blotting. We first assessed whether RAB5B
messenger RNA (mRNA) (as well as RAB5A and RAB5C) was
expressed in normal infant lung AT2 cells, the site of surfactant
4 of 10 j PNAS
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Fig. 2. C. elegans rab-5[D135H] produces a dominant negative RAB-5 small
GTPase. (A) Illustration of the endogenous rab-5 locus on chromosome I and
the single-copy genomic wild-type rab-5 transgene integrated into a safe
harbor locus on chromosome II. (B) Mean locomotion speed and worm
length on growth media agar plates for the wild-type, rab-5(del) heterozygotes, rab-5[D135D]#1 control edit heterozygotes, rab-5[D135H]#1 heterozygotes, and rab-5[D135H]#2 heterozygotes (tested animals were crossprogeny from mating). (C) Locomotion speed and mean worm length on
growth media agar plates. The wild type and the wild type homozygous for
the single wild-type copy insertion of rab-5 on chromosome II (light gray)
were self-progeny, while rab-5[D135H]#2 heterozygotes with the normal
version of chromosome II hemizygous or homozygous for the chromosome II
containing a single wild-type copy of rab-5 (dark gray) were cross-progeny
from mating. Allele designations for independent edits (#1, #2) are in SI
Appendix, Table S2. Three independent biological replicates were combined
for each genotype. n ≥ 46 per condition, except for rab-5[D135H]#2 heterozygotes in C (n = 29). Scatterplots showing mean and SD are presented for
locomotion speed. Filled circles indicate the average speed per animal for up
to 1 min. Box plots indicate the mean and ﬁrst and third quartiles, and
whiskers indicate the 5th and 95th percentiles for measures of animal
length. Differences between groups were determined by the Student’s
t test. ns, not signiﬁcant. ***P < 0.001.

Fig. 3. Defective endocytic uptake and fusion in C. elegans rab-5[D135H]
heterozygotes. (A) Steady-state ssGFP level imaged in rab-5[D135D]#1 control edit heterozygous animals 24 h post-L4. Schematic (Left) and confocal
(Right) image showing rapid endocytic uptake of ssGFP from the body
cavity into coelomocytes. (B) Steady-state ssGFP level imaged in
rab-5[D135H]#1 heterozygous animals 24 h post-L4. Schematic (Left) and
confocal (Right) image showing accumulation of ssGFP in the body cavity
with limited uptake in coelomocytes. Arrowheads indicate ssGFP in coelomocytes. Quantiﬁcation of the staining pattern data is in SI Appendix, Fig.
S4A. (Scale bars: 50 μm.) (C–E) 2xFYVE::GFP-labeled EEs imaged in coelomocytes of rab-5(del) heterozygotes (C), rab-5[D135D]#1 control edited
heterozygotes (D), and rab-5[D135H]#1 heterozygotes (E). Arrows indicate
large ring-shaped EE. Arrowheads indicate small puncta-sized EE. (Scale
bars: 10 μm.) (F) Quantiﬁcation of ring-shaped large EE and puncta-sized
EE in coelomocytes of rab-5(del) heterozygotes, rab-5[D135D]#1 heterozygotes, and rab-5[D135H]#1 and rab-5[D135H]#2 heterozygotes as in C–E.
n ≥18 coelomocytes from at least ﬁve animals per genotype. Allele designations for independent edits (#1, #2) are in SI Appendix, Table S2. Coelomocytes are very large professional cells specialized in endocytic uptake
and thus, have large EE, facilitating analysis. ns, not signiﬁcant.
**P < 0.005; ***P < 0.001 determined by the Mann–Whitney U test.
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(A) AT2 cell hyperplasia in the proband (hematoxylin and eosin). (B) Immunostaining for pan-RAB5 and RAB5B (SI Appendix, Figs. S13 and S14). Differential interference contrast (DIC) microscopy, together with staining, shows lung structure, with a pentagonal alveolar organization in the normal donor
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for proSP-C, mature SP-C, proSP-B, and mature SP-B. (I and J) ABCA3 and mature SP-C staining and ABCA3 and mature SP-B staining, respectively, in individual cells. Images in A, B, D, E, G, I, and J are representative of n = 3 to 4 normal donor lungs. Nuclei were stained with 40 ,6-diamidino-2-phenylindole
(DAPI). Shown in C, F, and H are plots of relative ﬂuorescent intensity of cells from n = 4 to 6 images from each condition analyzed by the two-tailed Student’s t test. ns, not signiﬁcant. ***P < 0.001.
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As an initial evaluation, we stained normal (transplant
donor) and proband lung sections with an antibody that reacts
with RAB5A, RAB5B, and RAB5C (pan-RAB5) together with
an RAB5B-specific antibody (SI Appendix, SI Materials and
Methods and Fig. S8 have assessment of the specificity of the
RAB5 antibodies). The pan-RAB5 antibody stained both normal and proband lung tissue (Fig. 4 B and D), although immunofluorescent staining was more extensive in the proband due
to AT2 cell hyperplasia (AT2 cells were identified by proSP-B,
proSP-C, and ABCA3 immunostaining [SI Appendix, Figs. S13
and S14]). In contrast, while RAB5B-specific staining was
observed in the normal lung, the fluorescent signal was significantly reduced in the proband’s lung tissue. Quantification indicated an ∼80% reduction in RAB5B staining in the proband vs.
normal AT2 cells, while pan-RAB5 staining showed an ∼20%
reduction in proband vs. normal lung (Fig. 4 C and D). In contrast, there was no obvious change in RAB5B staining in lung
tissues and AT2 cells in patients with surfactant protein dysfunction disorders resulting from pathogenic variants in SFTPB,
SFTPC, or ABCA3 (SI Appendix, Figs. S9–S11 and S14; variants
information is in SI Appendix, SI Materials and Methods), indicating that the reduction in RAB5B staining in the proband is
not a consequence of a surfactant dysfunction disorder. The
reduction in RAB5B staining in AT2 cells is consistent with the
dominant negative RAB5B p.D136H allele contributing to the
proband’s ILD.
The reduction of RAB5B staining in the proband could be
because the dominant negative RAB5B variant leads to the degradation of RAB5B or leads to reduced GTP binding, resulting
in diffuse cytoplasmic staining. To address this possibility in the
absence of a suitable proband lung sample for western blot, we
assessed the level of RAB-5 protein in C. elegans by western
blotting employing an anti–RAB-5 antibody preparation (43).
The RAB-5 band was identified by its substantial knockdown
following rab-5 RNA interference (RNAi) feeding and its
molecular weight (SI Appendix, Fig. S3C). We found that the
RAB-5 level was significantly reduced in rab-5[D135H] heterozygotes compared with control edit rab-5[D135D] heterozygotes, with a similar or slightly greater decrease relative to
rab-5(del) heterozygotes (SI Appendix, Fig. S3 E and F). The
decrease in RAB-5 level in variant heterozygotes, in contrast to
deletion heterozygotes, is likely a result of protein degradation.
Unfortunately, we were unable to evaluate the subcellular distribution of RAB-5 and RAB-5[D135H] as the antibody staining in the intestine of the wild type was not altered following
rab-5 RNAi. This result may be due to cross-reaction with C.
elegans proteins larger and/or smaller than RAB-5 observed in
the western blot (Materials and Methods and SI Appendix, Fig.
S3C). The C. elegans results with the RAB-5[D135H] heterozygous strains suggest that the reduced RAB5B staining in proband AT2 cells is, at least in part, due to protein degradation.
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Disruption of Mature SP-B and SP-C Production in the Proband
Lung. To more thoroughly investigate and provide insight into

the possible disorder of surfactant dysfunction, we immunostained normal and proband lung sections for proSP-B or
mature SP-B as well as proSP-C or mature SP-C (Fig. 4 E–H
and SI Appendix, Fig. S13; SI Appendix, Figs. S9–S12 show
assessment of the specificity of the surfactant protein antibodies). proSP-B and proSP-C staining signal intensity per cell was
similar in normal and proband lung tissue, with more extensive
staining in the proband lung due to AT2 cell hyperplasia. In
contrast, the mature SP-B and SP-C staining signal was significantly reduced by ∼66% in the proband vs. normal AT2 cells.
The presence of the precursor proteins but not the mature
SP-B and SP-C indicates that there is a defect in trafficking/
processing in the vesicular pathway for production of mature
SP-B and SP-C. These results are consistent with the decreased
6 of 10 j PNAS
https://doi.org/10.1073/pnas.2105228119

levels of mature SP-B and SP-C causing a disorder of surfactant
dysfunction and ILD in the proband.
ABCA3 is an ABC transporter family member that transports phospholipids into the lamellar body to generate the
functional surfactant protein–lipid complex. ABCA3, like
proSP-B and proSP-C, is synthesized in the ER and trafficked
to the lamellar body, potentially by the same vesicular pathway
used for the surfactant protein trafficking. To address this possibility, we stained normal donor and proband lung sections for
ABCA3 (Fig. 4 I and J and SI Appendix, Figs. S12, S13, and
S15). We observed the previously reported ring-like ABCA3
stained structures (44, 45), with similar intensity and organization, in both normal and proband AT2 cells, while mature SP-B
and SP-C staining was significantly reduced only in the proband. The typical staining of ABCA3 in the proband suggests
that ABCA3 is trafficked by a different pathway, at least at the
level of RAB5, from the surfactant proteins proSP-B and
proSP-C. Additionally, the staining showed that lamellar
body organization, at least relative to the distribution of
ABCA3 immunostaining, was similar in the proband and
normal lung.
proSP-B and proSP-C Colocalize with RAB5B and EEA1 in Normal
Donor AT2 Cells. How might RAB5B function in the accumula-

tion of mature SP-B and SP-C while not necessary for the accumulation of proSP-B and proSP-C? RAB5B and EEs have
recently been found to have a noncanonical function in the regulated secretion pathways in mammalian mast cells and the
Drosophila salivary gland (8, 9). RAB5B-associated EEs may
similarly fuse with small sorting vesicles containing proSP-B
and proSP-C in the surfactant secretion pathway. Alternatively,
it is known that extracellular mature SP-B and SP-C are
recycled by AT2 cells for repackaging into the lamellar body or
trafficked to the lysosomes for degradation (46, 47), presumably
through the canonical RAB5B-dependent endocytic pathway.
If RAB5B and EEs have a noncanonical function in the regulated secretion pathway for surfactant, we predict that in normal lung, proSP-B and proSP-C would colocalize with RAB5B
and EE marker EEA1, and that colocalization with EEA1
would be lost in the proband lung. In contrast, if RAB5B functions only in endocytic recycling/degradation of extracellular
mature SP-B and SP-C, colocalization of RAB5B with proSP-B
and proSP-C is not expected. Significantly, staining for RAB5B
and for proSP-B or proSP-C showed colocalization in normal
lung (Fig. 5A). Furthermore, proSP-B or proSP-C and EEA1
also showed colocalization in normal lung (Fig. 5 D and E).
While proSP-B and proSP-C staining was similar between normal and proband AT2 cells, EEA1 staining was significantly
reduced in the proband lung (Fig. 5 B and C), precluding
assessment of colocalization in proband AT2 cells. Since EE
localization of EEA1 is dependent on activated RAB5B, the
decreased staining of EEA1 in the proband lung is likely due to
the dominant negative RAB5B p.D136H. The colocalization of
RAB5B with proSP-B and proSP-C, as well as of EEA1 with
proSP-B and proSP-C in normal lung, is consistent with
RAB5B-dependent fusion of nascent sorting vesicles containing
proSP-B and proSP-C with EEs to form small sorting vesicles in
the regulated surfactant secretion pathway.
We also examined canonical endocytic recycling of mature
SP-B and SP-C. In normal lung, EEA1 colocalized with mature
SP-B and SP-C (Fig. 5 D and E). Mature SP-C staining also
showed colocalization with pan-RAB5 and RAB5B (Fig. 5F).
These results suggest that RAB5B, as well as RAB5A and
RAB5C, functions in endocytic recycling of extracellular
mature surfactant proteins and is consistent with RAB5B
and RAB5C being identified in the lamellar body proteome
(48). A function in endocytic recycling of mature SP-B and
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Fig. 5. Colocalization of proSP-B and proSP-C with RAB5B and EEA1 in donor AT2 cells. Tissue sections from normal donor lung were immunostained
with antibodies for the indicated protein. (A) Colocalization of RAB5B and proSP-C or RAB5B and proSP-B (arrows) in single cells. (B) EEA1 staining.
(Upper) Normal donor. (Lower) Proband. (Left) Low-power image; arrowheads indicate a subset of AT2 cells. (Right) Single-cell confocal micrographs are
shown. (C) Quantiﬁcation of EEA1 staining from low-power images in B. ***P < 0.001, two-tailed Student’s t test. (D and E) Normal donor lung EEA1 and
proSP-C or mature SP-C and EEA1 with proSP-B or mature SP-B, respectively, in single cells. (F) Pan-RAB5, RAB5B, and mature SP-C in normal lung. Arrows
in A, D, E, and F indicate colocalization of markers in cytoplasm. Images in A, B, D, E, and F are representative images of n = 3 to 4 normal donor lungs.
Nuclei were stained with DAPI. Shown in C is the mean ﬂuorescent intensity of immunostained cells from n = 4 images for each condition. (Scale bars:
A, B, Right, D, E, and F, 5 μm; B, Left, 20 μm.)

SP-C (Fig. 5 D–F) provides an explanation of why some
RAB5B did not colocalize with proSP-B and proSP-C (Fig. 5A)
in the regulated surfactant secretion pathway.
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Rab5b-Specific mRNA Knockdown in MLE-15 Cells Results in a
Defect in the Formation of Mature SP-B. The above analysis sug-

gests that RAB5B may specifically function in a noncanonical
EE fusion event with proSP-B– and proSP-C–containing
nascent early sorting vesicles in surfactant trafficking/processing. Accordingly, we performed Rab5b-specific knockdown
using short hairpin RNAs (shRNAs) in MLE-15 cells. The
MLE-15 cell line has AT2 characteristics, was derived from a
transgenic mouse with an SV40 transformed lung, and has previously been employed to investigate the processing of proSP-B
(49) (SI Appendix, Fig. S16). For two different shRNAs,
RAB5B protein, but not total RAB5 protein, was significantly
knocked down (Fig. 6A and SI Appendix, Fig. S16). In a western
Huang et al.
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blot assay to distinguish between precursor and processed SP-B,
Rab5b shRNA knockdown did not result in a significant change
in proSP-B compared with control shRNA treatment (Fig. 6). In
contrast, Rab5b knockdown resulted in a significant reduction in
the mature SP-B band (Fig. 6). The RAB5B-specific knockdown
in MLE-15 cells recapitulates the failure to generate mature
SP-B from proSP-B observed in the RAB5B p.D136H proband
lung, likely due to an EE vesicular trafficking defect. Together,
these results support that RAB5B has an essential function in
the regulated secretion pathway for lung surfactant.
Discussion
We present evidence that the de novo heterozygous RAB5B
p.D136H variant results in a disorder of surfactant dysfunction.
The p.D136H variant is not found in gnomAD, is bioinformatically predicted to be damaging, and based on crystal structure,
PNAS j 7 of 10
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Fig. 6. Rab5b knockdown in MLE-15 cells decreases mature SP-B production. MEL-15 cells were transduced with lentiviruses that express nontargeted
control shRNA or Rab5b-speciﬁc shRNA sequences (shRNA1, shRNA2) after selection for 5 d in puromycin. (A) Western blot analysis of transduced MLE-15
cells using antibodies to detect RAB5B, pan-RAB5 (total RAB5), mature SP-B, proSP-B, and ACTIN. (B) Quantiﬁcation of the western blot signal for RAB5B,
total RAB5, mature SP-B, and proSP-B from MLE-15 cells transduced with control shRNA, Rab5b shRNA1, and Rab5b shRNA2 from four independent
transductions. Multiple medians were compared using the Kruskal–Wallis test followed by Dunn’s multiple comparison. ns, not signiﬁcant. ***P < 0.001.

resides in the fourth nucleotide binding domain of Rab/Ras family small GTPases. However, RAB5B is not a haplo-insufficient
gene. Functional studies with the C. elegans ortholog demonstrated that the variant was damaging in vivo, resulting from the
production of a strong dominant negative gene product and providing a genetic mechanism for the de novo dominant presentation. Worm studies also showed that the variant was defective in
endocytosis, was defective in heterotypic nascent endocytic/sorting vesicle–EE fusion and/or homotypic EE fusion, and led to
degradation of the RAB-5 protein. Defects in RAB5B and
EEA1 in the proband as a result of the p.D136H variant were
supported by histological analysis of the proband’s lung biopsy
showing that RAB5B and EEA1 staining was significantly
reduced. The reduction in RAB5B was shown not to be an effect
of ILD, as it was not observed in other cases with pathogenic variants in known surfactant dysfunction disorder genes. Notably,
proband lung staining revealed a disruption in the generation of
mature SP-B and SP-C from proSP-B and proSP-C, respectively.
Importantly, a requirement for RAB5B function in the production of mature SP-B was recapitulated in cell culture. Furthermore, in normal lung, RAB5B and EEA1 colocalized with
proSP-B and proSP-C, indicating a role for RAB5B and EEs in
normal surfactant biogenesis. This function appears to be unique
to RAB5B, but not coexpressed paralogs RAB5A and RAB5C, in
AT2 cells. RAB5 paralog–specific functions have been reported
for other aspects of biology: for example, epidermal growth factor
receptor (EGFR) trafficking (50), RAC GTPase-mediated cell
motility (51), and hematopoietic stem and progenitor cell development (52).
The lung phenotype of the proband was less pronounced
than that of infants with biallelic loss-of-function variants in
SFTPB who present with lethal neonatal respiratory distress
syndrome and more similar to patients with SFTPC dominant
variants (10, 19, 20) who demonstrate variable age of ILD
onset, severity, and progression. This difference suggests that in
the RAB5B p.D136H heterozygous proband, there was partial
production of mature surfactant protein B through the regulated surfactant secretion pathway, which was sufficient at birth
but ultimately, inadequate and led to lung injury in early life.
While this work provides evidence for a direct role of the
RAB5B p.D136H variant in the trafficking/processing of SP-B
and SP-C, it does not address the dysmorphic features or
8 of 10 j PNAS
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neurological phenotype of the proband. However, given the
widespread expression including the brain (https://gtexportal.
org/home/gene/RAB5B) and the recent finding that RAB5C
functions in hematopoietic stem and progenitor cell development (52), RAB5B may have analogous paralog-specific functions in facial, digit, and/or neural development.
The production of mature SP-B and SP-C in AT2 cells by the
regulated surfactant secretion pathway has been described
(12–16) (Fig. 7). We propose, as a refinement of this pathway,
that the nascent sorting vesicles containing proSP-B or proSP-C
undergo RAB5B-dependent fusion with EEs, which then
mature into MVBs en route to lamellar bodies. This proposal is
consistent with colocalization of proSP-B and proSP-C with
RAB5B and EEA1, with subsequent acidification during vesicular progression through the regulated secretion pathway resulting in proteolytic processing to form mature SP-B and SP-C
and with recent reports of Rab5 and EEs functioning in vesicular progression in mammalian mast cells and the Drosophila salivary gland–regulated secretion pathways (8, 9). We further
propose that in the proband lung, productive fusion of EEs
with the nascent sorting vesicles containing proSP-B or proSPC is disrupted because of the RAB5B p.D136H variant, resulting in a failure to traffic prosurfactant proteins to the MVBs/
lamellar bodies (Fig. 7). In contrast, ABCA3 trafficking and
formation of the ABCA3 compartment of the lamellar body
appear to be normal in the proband. Thus, the failure to
produce mature SP-B and SP-C is proposed to be a result of
defective vesicular trafficking rather than a failure in protein
processing per se. We note that while we observe a defect in
the production of both mature SP-B and SP-C in the proband,
SP-B function is needed for the generation of mature SP-C (17,
22, 53), so it is possible that only proSP-B trafficking is disrupted by the RAB5B D136H variant protein.
The C. elegans experiments revealed that RAB-5 protein is
degraded in rab-5[D135H] heterozygous animals. However, the
gene dosage studies demonstrated that it is not the reduced levels of RAB-5 causing the heterozygous mutant phenotypes but
the dominant negative poisonous D135H gene product, which
requires three wild-type rab-5 copies to fully restore normal
phenotypes. Instead, the degradation of RAB-5 is likely a secondary effect of the dominant negative protein. By extension,
the significantly reduced RAB5B level in proband AT2 cells is
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likely due to protein degradation, a secondary effect of the dominant negative RAB5B p.D136H gene product. RAB5B D136H
could be removed by a ubiquitin-mediated degradation process.
Alternatively, aberrant EEs containing RAB5B D136H, possibly
engaged in defective fusion with proSP-B or proSP-C containing
nascent sorting vesicles, could be recognized as abnormal and
removed through autophagy (54). This latter possibility is
intriguing as it could also explain both the reduced levels of
EEA1 and the ultimate fate of the surfactant proteins as well as
why levels of proSP-B and proSP-C did not build up in proband
AT2 cells when vesicular trafficking was disrupted.
A limitation of this work is that proband lung tissue samples
for transmission electron microscopy to assess vesicular and
lamellar body ultrastructure and for western blotting to assess
processing of the endogenous surfactant proteins were not
available. Mouse knock-in models of Rab5B p.D136H as well as
Rab5B AT2 cell conditional knockout should allow testing of
the model (Fig. 7) and assessment of whether the other phenotypes in the proband (e.g., neurological phenotypes) are also
caused by the dominant negative RAB5B variant.
In summary, we have used modeling in C. elegans, knockdown studies in MLE-15 cells, and staining of proband lung tissue to provide evidence that the de novo heterozygous RAB5B
p.D136H allele is a genetic mechanism causing surfactant dysfunction that was previously unknown. Currently, this is a single
case, however, it is likely other RAB5B variants, especially dominant negative variants or compound heterozygous variants,
may cause disease. We suggest that for infants and children
with ILD consistent with a disorder of surfactant dysfunction in
whom a pathogenic variant in the established surfactant disease
genes is not found, the RAB5B locus be sequenced.

C. elegans Culture and Strain Information. C. elegans strains were cultured on
standard nematode growth media seeded with OP50 Escherichia coli and
grown at 20 °C (55). rab-5[D135H] heterozygous animals showed signiﬁcant
cold sensitivity, although they can be very slowly propagated at 15 °C; we,
therefore, maintained all rab-5[D135H] and corresponding control strains at
22 °C and assayed them at 20 °C. Strains and alleles used in this study are listed
in SI Appendix, Table S2.
C. elegans CRISPR-Cas9 Gene Editing. Single-nucleotide changes were introduced by editing the VC2010 animals with CRISPR-Cas9 (56, 57) (SI Appendix,
Table S3). A single-copy rab-5 transgene was integrated at Mos1 transposon
insertion site ttTi5605 on chromosome II (II: 0.77cM) (58) through CRISPR-Cas9
using the self-excising cassette method (59). All CRISPR-edited strains were
backcrossed at least twice.
WormLab Assays and Analyses. Crawling assays were performed using the
WormLab system (MBF Bioscience) for individual worm tracking and analysis.
Age/stage-matched young adults were analyzed for locomotion and size (60).
Assays for endocytosis were performed by crossing into various marker strains
and tested in cross-progeny. Images were analyzed using LASX (Leica Microsystems) and Volocity (v6.3; Quorum Technologies).
Immunostaining and Image Analysis. Tissue sections were processed and
immunostained using primary antibodies as in SI Appendix, Table S4. Images
for lung sections were acquired using an epiﬂuorescent or laser scanning confocal microscope and were then analyzed for ﬂuorescent intensity in FIJI (61).

Rab5b RNAi. Control nontargeted (SHC002; Sigma-Aldrich) and mouse Rab5bspeciﬁc shRNAs (Sigma-Aldrich) (SI Appendix, Table S5) were used to produce
lentivirus and transduce MLE-15 cells similar to the methods previously
described (62).
Immunoblot Analysis. Proteins from MLE-15 cells were separated onto 4 to
12% gradient polyacrylamide gels. Membranes were incubated with the primary and secondary antibodies in SI Appendix, Table S4. The density of bands
was quantiﬁed relative to ACTIN in FIJI.

Materials and Methods
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The SI Appendix has more details.
Human Studies. Written consent for genetic studies, for use of tissue for
research, and to publish photographs was obtained from the proband’s
parents. Genetic and tissue studies were approved by the institutional review
boards (IRBs) at Washington University in St. Louis and Baylor College of Medicine. The UDN protocol, 15-HG-0130, was approved by the National Human
Genome Research Institute IRB. Nondiseased control lungs were those
donated but unsuitable for transplantation. Lung sections from individuals
with disorders of surfactant dysfunction due to pathogenic variants in SFTPB,
SFTPC, and ABCA3 were used for comparisons with the immunostaining from
the proband. Parents provided written consent, and the study was approved
by the IRB at Washington University School of Medicine in St. Louis.
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Statistics. Statistical analysis was performed using GraphPad Prism (version
6.07). Differences between two groups were compared using the two-tailed
Student’s t test or the Mann–Whitney U test. Multiple medians were compared using the Kruskal–Wallis test followed by Dunn’s multiple comparison.
P < 0.01 indicates statistically signiﬁcant difference, unless otherwise stated.
Box plots show the median, a box representing the ﬁrst and third quartiles,
and whiskers at the 5th and 95th percentiles.
Data Availability. All study data are included in the article and/or SI Appendix.
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Fig. 7. Potential role for RAB5B in the surfactant protein–regulated secretion pathway. A model showing the regulated secretion pathway for surfactant
in AT2 cells. Surfactant protein precursors proSP-B and proSP-C are translated in the ER and trafﬁcked to the Golgi, where they bud off as cargo in nascent
sorting vesicles. We propose that RAB5B-associated EEs fuse with prosurfactant containing nascent sorting vesicles to form small sorting vesicles, which subsequently fuse with the MVB, and then progress to the lamellar body for maturation and storage. Acidiﬁcation during vesicular trafﬁcking results in processing of proSP-B and proSP-C to mature SP-B and SP-C in the MVB/lamellar body. We further propose that dominant negative RAB5B p.D136H in the proband
led to aberrant EEs that were defective in productive fusion with prosurfactant containing nascent sorting vesicles to generate functional small sorting
vesicles (indicated by red X). We speculate that aberrant EEs containing RAB5B D136H, potentially as arrested fusion intermediates with nascent sorting
vesicles containing proSP-B or proSP-C, are degraded. Such a mechanism would provide an explanation for reduced RAB5B as well as reduced EEA1 and the
signiﬁcant reduction of mature SP-B and SP-C. It is unknown if proSP-B and proSP-C are trafﬁcked in the same or separate vesicles.
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